1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSBI Research and Education Fund Seed Grant is sponsored by Society of Breast Imaging (SBI). Provides grants for pilot and early-stage research related to breast cancer imaging and patient experience.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
SBI Research and Education Fund Seed Grant - Society of Breast Imaging The SBI Research and Education (R&E) Fund will provide grants for scientifically rigorous pilot and/or early-stage research broadly related to imaging and the patient experience of screening, diagnosis, or treatment of breast cancer.
The goal is to seed innovative breast imaging research that improves patient outcomes, fosters investigator career development, and catalyzes future external funding. The R&E Fund will promote research and researchers within the SBI membership.
Funding is available to SBI members who have not been a Principal Investigator (PI) on a single project of $100,000 or more and who work in the United States or Canada Investigators from all stages of their careers, including trainees, are eligible. Participation from early- and mid-career investigators is encouraged.
Projects must be related to breast imaging, including screening, diagnosis, treatment, enhancing the patient experience, or breast imaging as a career Eligible Organizations: Applicants can be affiliated with academic institutions or Clinical and Community-Based Organizations Applicants who are from underrepresented groups are strongly encouraged to apply Up to $40,000 for a 1-year project Indirect costs are not allowed Salary support for the principal investigator is allowed July 15, 2026 Call for proposals Sept 15, 2026 Submission Deadline Nov 1, 2026 Committee study section Dec, 2026 Board selection of winning proposal March 15, 2027 Earliest start date of funding April/May 2028 Presentation of research at SBI annual meeting The application should be submitted through the portal and the required components are: Title page (title, PI, institution, keywords (5 maximum)) Abstract (300 words or less) Detailed Budget with Justification Please provide a justification for each budgeted item Name(s) of Investigator(s).
The role of each investigator must be clearly articulated and percentage contribution of each investigator clearly described in the budget justification section Indirect charges are not allowed.
A biosketch for the PI and all investigators in the NIH-format (maximum five pages each) Description of the Research (Three-page maximum) Should include (i) specific aims, (ii) background and the significance of the expected results, and (iii) research methods including any preliminary data if available (not required); include references (not included in the page count) Describe the availability of any equipment needed for the project Include a description of the research milestones you intend to achieve and when: One-half (1/2) page maximum.
This can be graphical and/or text. The full grant term is expected to be no more than 12 months. No-cost extensions may be allowed for extenuating circumstances.
Letter from chair and any external collaborators A letter of support from the applicant’s department chair that includes the amount of time that the PI will be given to work on the project (e.g., hours per week). Trainee applicants should submit a letter of support from their project mentor.
Applicants from private practice should submit a letter explaining how they will make time to do the research and a letter from a supervisor stating that the research project is feasible in the clinic setting, if applicable. For each investigator who is not in the same Department as the PI, please provide a letter of commitment.
Description of applicant’s current employment position and how these grant funds and resources will be used to leverage future grants and support their career development. Please also describe any internal or external sources of funding for this research, either existing, pending, and/or plans to apply. One (1) page maximum.
Description of Conflicts of Interest Describe any conflicts of interest and how they will be managed. State “none” if there are no conflicts of interest. Follow the NIH format for margin size (0.
5” margins) and font type and size (Arial or Helvetica, or Georgia, 11 pt for main, 10 or 11 pt for Tables and Figure Captions). Successful applicants will be expected to comply with all research assurances that involve: Ionizing Radiation/Radioactive Isotopes Other, requiring institutional research assurance approvals (recombinant DNA, etc.) Proposals will be evaluated by a panel of reviewers with relevant expertise.
The R&E committee will select the top proposal(s) based on reviews to be considered for funding by the Board. The Board will then make the final selection of the proposal(s) to be funded. Reviewers will consider each of the review criteria below and give a separate score for each.
An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project may not by its nature be innovative but may be essential to advance the field. The overall score is not an average of the individual scores for the items below, but each reviewer will weigh each individual score to arrive at a final overall impact score.
Does the project address an important problem or a critical barrier to progress in breast imaging? Is the supporting evidence provided rigorous (preliminary results are not required)? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved?
How will successful completion of the aims change the concepts, methods, technologies, and ultimately patient care that drive the field? Are the PI, collaborators, and other researchers well suited to the project? Does the project have sufficient expertise to ensure that the project can be successfully completed?
What, if any, expertise is missing? Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to the field or novel in a broad sense?
Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed? Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Have the investigators presented strategies to ensure a robust and unbiased approach, as appropriate for the work proposed?
Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed? Is there alignment between project aims and available resources?
Is the proposed project likely to succeed and lead to future funding at a higher level? The SBI board may choose to identify specific themes or focus areas for the seed grant program, which would be advertised at the time of the program announcement. For the inaugural launch, the focus must only be related to breast imaging, and all research plans are open for consideration.
Upon selection for funding, the PI will be paired with a senior member of the SBI who will be their external mentor. The external mentor and PI will meet regularly (virtually) to discuss research progress and address any research concerns. A brief (approximately 1 page) update on research progress towards milestones and specific aims is required 6 months after funding begins.
A full summary of the research project is required at the end of the funding period. The Principal Investigator (PI) is expected to present an overview of their research at the SBI annual meeting for the year following the start of their funding A financial report is due at the end of the project to ensure funds were used as intended along with the full summary of the research project.
A final written report on the outcomes of the project is required.
According to the current listing, eligibility includes: SBI members who have not been a Principal Investigator on a project of $100,000 or more. Confirm the full requirements in the official notice before applying.
The published deadline was September 15, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
SBI Research and Education Fund Seed Grant is funded by Society of Breast Imaging (SBI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe National Science Foundation announced $1.5 billion over a decade for X-Labs — milestone-based, Other Transactions Authority awards built around independent teams of researchers, engineers, and entrepreneurs. The first two topics target quantum-enabled imaging and quantum interconnects. Here is what the new mechanism means for traditional grantees and what the first round actually demands.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article